Adverum Biotechnologies, Inc
Adverum Biotechnologies, Inc., based in Redwood City, CA, is dedicated to redefining the standard of care for debilitating ocular diseases through gene therapy. The company's lead program focuses on wet age-related macular degeneration, aiming to develop functional cures that restore vision and prevent blindness by offering a long-lasting, single-administration treatment option.
Utilizing a proprietary next-generation adeno-associated virus vector platform, Adverum's investigational therapy Ixo-vec converts retinal cells into continuous therapeutic protein biofactories. This innovative approach aims to alleviate the burden of frequent eye injections while improving accessibility to effective treatments for patients suffering from sight-threatening conditions.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.